NCT02244151View on ClinicalTrials.gov

Evaluation of Time Interval Between Ovulation Trigger With Triptorelin Acetate and Oocyte Retrieval

PHASE2CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

February 1, 2018

Study Completion Date

February 2, 2018

Conditions
Female Urogenital Diseases
Interventions
DRUG

Decapeptyl® diario

Decapeptyl® daily administration (Triptorelin acetate) and follicular puncture at 24, 30, 36 or 40 after administration.

DRUG

Decapeptyl® daily

Decapeptyl® daily OPU 36 hrs after GnRH administration

Trial Locations (1)

46026

Instituto de Investigacion Sanitaria La Fe, Valencia

All Listed Sponsors
lead

Instituto de Investigacion Sanitaria La Fe

OTHER

NCT02244151 - Evaluation of Time Interval Between Ovulation Trigger With Triptorelin Acetate and Oocyte Retrieval | Biotech Hunter | Biotech Hunter